Cost effectiveness of intradermal vs. subcutaneous hepatitis b vaccination for the mentally handicapped
- 31 July 1991
- journal article
- clinical trial
- Published by Elsevier in Journal of Infection
- Vol. 23 (1) , 39-45
- https://doi.org/10.1016/0163-4453(91)94019-g
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Intradermal hepatitis B vaccination for mentally retarded patientsJournal of Infection, 1989
- Comparison of results of recombinant and plasma-derived hepatitis B vaccines in Japanese nursery-school childrenJournal of Infection, 1988
- Low dose intradermal vaccination against hepatitis B in mentally retarded patientsVaccine, 1988
- REVERSAL BY INTRADERMAL HEPATITIS B VACCINATION OF UNRESPONSIVENESS TO HBsAgThe Lancet, 1987
- Intradermal vaccination against hepatitis B virus infection in an endemic area (Nigeria), two year resultsArchiv für die gesamte Virusforschung, 1986
- Safety and immunogenicity of a recombinant hepatitis B vaccineJournal of Medical Virology, 1985
- Development of DTH Skin Reaction to HBsAg in Individuals Immunized with HB VaccineMicrobiology and Immunology, 1984
- Hepatitis B Vaccination in Down’s Syndrome and Other Mentally Retarded PatientsHepatology, 1984
- Survey of Hepatitis B Viral Markers at a Public Day School and a Residential Institution Sharing Mentally Handicapped StudentsThe Journal of Infectious Diseases, 1984
- PREVALENCE OF HEPATITIS B INFECTION AMONG RESIDENTS OF AN INSTITUTION FOR THE MENTALLY RETARDEDAmerican Journal of Epidemiology, 1977